First study on the efficiency of <sup>99m</sup>Tc-rituximab for sentinel lymph node mapping and biopsy in oral squamous cell carcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Yang,Liu ^[1] ; Fei,Wang ^[1] ; Yufei,Song ^[1] ; Xiaochuan,Zhou ^[2] ; Xin,Zhou ^[1] ; Changzhi,Du ^[1] ; Yan,Cui ^[1] ; Yitong,Liu ^[1] ; Nan,Li ^[3]

作者单位： Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China. ^[1] Department of Nuclear Medicine, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, 157011, China. ^[2] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China. rainbow6283@sina.com. ^[3]

关键词 99mTc-rituximab Lymphoscintigraphy Oral squamous cell carcinoma Sentinel lymph node biopsy Sentinel lymph node mapping

DOI 10.1007/s12149-024-02012-5

PMID 39729190

发布时间 2024-12-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of nuclear medicine

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

First study on the efficiency of <sup>99m</sup>Tc-rituximab for sentinel lymph node mapping and biopsy in oral squamous cell carcinoma.

Annals of nuclear medicine

相似文献

Annals of nuclear medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

First study on the efficiency of <sup>99m</sup>Tc-rituximab for sentinel lymph node mapping and biopsy in oral squamous cell carcinoma.

Annals of nuclear medicine

相似文献

Annals of nuclear medicine

相关期刊

检索历史清除